Charming Medical (MCTA) Faces Class Action Over Alleged Stock Price Manipulation
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Source: Newsfilter
- Litigation Timeline: Investors must apply to be lead plaintiffs by February 17, 2026, covering those who purchased Charming Medical shares between October 21 and November 12, 2025, highlighting the urgency of the legal action.
- Stock Price Surge: Following its IPO, Charming Medical's stock price skyrocketed from $4.00 to $29.36 per share without any fundamental news, indicating potential market manipulation.
- Social Media Manipulation: The lawsuit alleges that the price increase was driven by fraudulent promotions from impersonators posing as financial advisors on social media, leading retail investors to make uninformed purchases and suffer losses.
- Trading Suspension Impact: In November 2025, trading of Charming Medical securities was suspended, revealing the artificial nature of the price surge and exacerbating financial losses and legal risks for investors.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
